The Centre has approved investment of Rs 6000 crore to 74 industries in the pharmaceutical and medical device manufacturing sectors under the production linked incentive (PLI) scheme, Union Home Minister Amit Shah said here on Saturday. Shah was addressing a gathering after dedicating the newly built campus of the National Institute of Pharmaceutical Education and Research (NIPER) at Gandhinagar. "The Union government has taken a holistic approach and begun the process for the development of a cost-effective, sustainable and affordable process for 16 APIs (active pharmaceutical ingredient) and two KSMs (key starting material)," he said. In the next one decade, India will not just become self-reliant but also be in a position to export them (APIs and KSMs), Shah added. "The Narendra Modi government has given permission for the investment of Rs 4000 crore to about 48 small and big industries in the sector of pharmaceutical manufacturing under the PLI scheme," Shah said. The PLI sche
ARPOB refers to the average revenue per operating bed which has gone up from Rs 37,397 in FY20 to Rs 57,760 for the first quarter of the ongoing financial year
The pricing policy is a part of the National Medical Device Policy 2023 launched by the government to facilitate the growth of the sector while also ensuring accessibility and affordability
Stalin's visit to Japan brings in investments worth Rs 1,300 crore
Omron will make devices including blood pressure monitors and will invest nearly 1.3 billion Indian rupees (about $15.7 million) to set up the plant, the sources said, declining to be identified ahead
The department of consumer affairs has mandated that pharmaceutical clearly display important information on their packaging so consumer can make informed decisions
Centre notifies the National Medical Devices Policy, 2023
What do the Q4 results tell us about rural demand? What went wrong with the FAME scheme? Will softening inflation bring respite to QSR stocks? What's the National Medical Devices Policy? Answers here
A three-day national event on the Indian medical devices sector will be organised in August alongside the G-20 health ministers meeting, the Ministry of Chemicals and Fertilizers said on Monday. To be held at Gandhi Nagar in Gujarat from August 18-20, the India MedTech Expo would help to create opportunities to network and explore collaborations in the medical device sector. The G-20 Health Ministers meeting has been scheduled on August 17-19 in Gandhi Nagar. Around 150-plus startups, more than 275 Indian and international medical device companies and MSME units and about 50 research institutions will be participating in the Expo, the Chemicals and Fertilizers ministry said in a statement. The proposed Expo will create visibility of the medical devices ecosystem to the world and build a brand identity for the Indian MedTech sector, it added. The current market size of the medical devices sector in India is estimated to be USD 11 billion and has the potential to reach USD 50 billio
The Maharashtra Medical Equipment Purchase Authority has been established to enable government purchases of medical equipment and medicines through a single body, Health Minister Tanaji Sawant said on Friday. The Health Department will also work to give a new lease of life to the state-run Haffkine Institute whose primary job is vaccine development and manufacturing, he said in a statement. A bill for the establishment of the authority was passed by both Houses of the state legislature in the ongoing Budget session. Until now every government department purchased necessary medical equipment and medicines separately, often at varying rates. Purchases of medicines, medical equipment, sonography machines, dialysis machines, ventilators, CT scan machines and furniture could be now made through this authority. Even the Union government and other states can make purchases through it. The authority will be chaired by the chief minister while the health minister, medical education minist
Group wants basic custom duty on import of medical devices increased to 10-15%
Shares of Nureca hit a 20-month low of Rs 562.50,down 3%, trading close to its record low of Rs 559.25 touched on March 19, 2021
Allows self declaration on portal for licensing purposes
All Class A and Class B med device makers to switch to licensing regime within; many are dealing with slow pace of govt audits or simply not clearing them
The organisation noted that the reduction of GST on medical devices and medical cold chain from 12 per cent to 5 per cent would lead to the expansion of the healthcare sector through reduced costs
Morepen Laboratories on Wednesday said its shareholders have approved to shift its medical devices business into a newly incorporated wholly-owned subsidiary
Centre has taken a key initiative to support the medical devices industry to reach its potential in the coming years under the "Promotion of Medical Device Parks" scheme
International SIM seller Matrix Cellular is bullish on growth in business due to adoption of e-SIM overseas, and expects 30-40 per cent year-on-year jump as foreign travelling opens up.
Patented technology of US firm, which tied up with DRDO last month, to save 66,500 more people in July-August
The purpose is to see if the states and the Centre can use its technology to tackle the issues arising from the pandemic.